Ledger.Open graph →
SEC Form D · filed September 17, 2021

Cambium Biomaterials, Inc

Offering
$28.0M
Sold
$8.0M
Exemption
Rule 506(b)
Industry
Other Technology
Location
BERKELEY, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Andrew Guenthner · BERKELEY, CAExecFrancisco Gimenez · San Carlos, CADirectorStephan Herrera · BERKELEY, CAExec · DirectorSimon Waddington · San Francisco, CAExec · DirectorAndrew Guenthner · BERKELEY, CAExecFrancisco Gimenez · San Carlos, CADirectorStephan Herrera · BERKELEY, CAExec · DirectorSimon Waddington · BERKELEY, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗